AMARIN CORP PLC\UK Senior Notes, Current
AMARIN CORP PLC\UK (AMRN) had Senior Notes, Current of $219.00 thousand as of 2018-09-30, per its 10-Q filed 2018-11-01.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Long-Term Debt, Current Maturities
us-gaap:SeniorNotesCurrent · last filed 2019-02-27
- 2018-09-30: Senior Notes, Current $219.00K.
- 2018-06-30: Senior Notes, Current $481.00K.
- 2018-03-31: Senior Notes, Current $219.00K.
- 2017-12-31: Senior Notes, Current $481.00K.
| Period end | Senior Notes, Current |
|---|---|
| 2018-09-30 | $219.00K 10-Q · filed 2018-11-01 |
| 2018-06-30 | $481.00K 10-Q · filed 2018-08-01 |
| 2018-03-31 | $219.00K 10-Q · filed 2018-05-02 |
| 2017-12-31 | $481.00K 10-K · filed 2019-02-27 |
| 2017-09-30 | $219.00K 10-Q · filed 2017-11-01 |
| 2017-06-30 | $455.00K 10-Q · filed 2017-08-02 |
| 2017-03-31 | $192.00K 10-Q · filed 2017-05-03 |
| 2016-12-31 | $15.35M 10-K · filed 2018-02-27 |
| 2016-09-30 | $15.27M 10-Q · filed 2016-11-03 |
| 2015-12-31 | $2.27M 10-K · filed 2017-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Processa Pharmaceuticals, Inc. (PCSA) | United States | $0.005B | |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B |